Besides, almost all of these cell lines had high half maximal inhibitory concentrations (IC50) and poor area-under-the-curve (AUC) sensitivity scores for TPCA-1, suggesting that amplification of PSMA7 might protect cancer cell lines from TPCA-1 treatment. Here, PSMA7 is linked to cancer.